You are viewing an expired study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Los Angeles, California

  • Diabetic Macular Edema

Purpose:

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of diabetic macular edema.


Criteria:

Key Inclusion Criteria: - 18 years of age or older with diabetic macular edema; - Decrease in visual acuity in at least one eye as a result of macular edema (20/50 or worse); - Visual acuity in other eye no worse than 20/200 Key Exclusion Criteria: - Known anticipated need for ocular surgery within first 12 months of study; - History of glaucoma or current high eye pressure requiring more than 1 medication; - Uncontrolled systemic disease; - Known steroid-responder; - Use of systemic steroids - Use of Warfarin/Heparin


NCT ID:

NCT00168389


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Los Angeles, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.